Scientists discover critical molecular biomarkers of preeclampsia

February 21, 2018, Tel Aviv University
Scientists discover critical molecular biomarkers of preeclampsia
Credit: Tel Aviv University

Preeclampsia, a sudden pregnancy complication that can interfere with the blood flow to the placenta and possibly to the fetus, can lead to low birth weight, prematurity and even death. It is also a leading cause of maternal mortality in the US. A new Tel Aviv University study identifies novel molecular biomarkers of preeclampsia, signaling the potential for an early diagnostic blood test.

Research for the study was led by Dr. Noam Shomron and Prof. Moshe Hod and conducted by Liron Yoffe and other lab members, all affiliated with TAU's Sackler School of Medicine, and in collaboration with Prof. Kypros Nicolaides of King's College, London. The conclusions were published in the journal Scientific Reports.

"Up to eight percent of pregnant women may contract during their second or third ," Dr. Shomron says. "This is a serious disease that endangers the health, sometimes even the lives, of the mother and the fetus. We don't know what causes it, but preeclampsia, if caught in time, has a simple and proven remedy: low doses of aspirin administered from the 16th week until the end of pregnancy."

Turning to genetics

Until now, medical practitioners have assessed a woman's risk of preeclampsia by referring to previous pregnancies, blood pressure levels and other general symptoms. "But we sought a definitive biomarker that appears in a patient's blood as early as the first trimester, before any symptoms appear," Dr, Shomron explains. "Our findings form the basis for a simple that would predict preeclampsia and, in turn, allow doctors to provide treatment that would prevent the very onset of the disease."

Over the course of six years, the researchers examined the blood samples from thousands of pregnant women in their first trimester from clinics in the UK. The team then narrowed their focused to 75 specific samples: 35 taken from women who eventually contracted preeclampsia, and 40 taken from those who completed their pregnancies in full health.

The researchers extracted the RNA molecules (snippets of molecular information present in human cells) from the plasma of the samples and sequenced these using Next Generation Sequencing (NGS). The scientists discovered the new biomarkers by analyzing the data using computational methods that included statistical analyses and machine learning algorithms.

"We identified 25 small RNA molecules that were differentially expressed between the preeclampsia and the control groups. Based on those RNA molecules, we then developed a model for the classification of preeclampsia samples," says Liron Yoffe. "These findings indicate the predictive value of circulating small RNA molecules in the first trimester, and lay the foundation for producing a novel early non-invasive diagnostic tool for preeclampsia, which could reduce the life-threatening risk for both the mother and fetus."

Early diagnosis leads to early prevention

According to Prof. Moshe Hod, the new research follows a global trend, which "seeks to establish pregnancy tests in the first trimester, as opposed to today, when most tests are performed in the third trimester."

Prof. Hod, the President of the European Association of Perinatal Medicine and Chairman of The International Federation of Obstetrics and Gynecology (FIGO) Committee that deals with maternal and offspring health, is leading a global effort to develop new diagnostic techniques to improve prediction and prevention of complications like gestational diabetes, preeclampsia and preterm birth in the first trimester of pregnancy.

"Early testing or prediction will allow doctors to safeguard the health of mother and fetus alike. It will also facilitate, if necessary, early preventive interventions to improve maternal and offspring's outcome," concludes Prof. Hod.

"The samples recently collected from other countries—Italy, Spain, Russia, and in particular Israel—will be used to apply our findings collectively to patients from around the world," adds Dr. Shomron.

Explore further: Detailed medical history best screening for preeclampsia

More information: Liron Yoffe et al, Early Detection of Preeclampsia Using Circulating Small non-coding RNA, Scientific Reports (2018). DOI: 10.1038/s41598-018-21604-6

Related Stories

Detailed medical history best screening for preeclampsia

August 23, 2015
(HealthDay)—Taking a detailed medical history remains the best and only recommended screening approach for preeclampsia, according to a practice bulletin published in the September issue of Obstetrics & Gynecology.

Fatty acid binding protein 4 tied to preeclampsia risk in T1DM

September 21, 2016
(HealthDay)—For women with type 1 diabetes, elevated fatty acid binding protein 4 (FABP4) in early pregnancy and in the second trimester is associated with subsequent preeclampsia, according to a study published online ...

Study finds elevated levels of cell-free DNA in first trimester do not predict preeclampsia

February 11, 2012
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that indicate that elevated levels of cell-free DNA in ...

Doctors develop new way to use MRI to predict pregnancy complications

December 6, 2017
UCLA scientists have developed a new way to use magnetic resonance imaging, or MRI, to scan the placenta. The noninvasive approach offers valuable insights into how the mother's blood enters the placenta and sustains the ...

New biomarker predicts development of preeclampsia at six weeks of pregnancy

November 23, 2015
Preeclampsia is generally diagnosed later in pregnancy, but new research could lead to diagnosis in the first trimester, improving care and potentially leading to the development of preventative measures.

New clinical trial at SLU treats preeclampsia in second-trimester pregnancies

September 24, 2015
Saint Louis University is participating in a Phase III clinical trial for a drug to treat early-onset preeclampsia in pregnant women that could increase the length of pregnancy, resulting in improved fetal outcomes and reduced ...

Recommended for you

Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort

March 19, 2018
A clinical trial comparing two treatments for postmenopausal vaginal discomfort - low-dose vaginal estrogen and a vaginal moisturizer - to placebo treatments found that both produced symptom improvements similar to those ...

Discovery promises improved diagnosis and understanding of endometriosis

March 19, 2018
Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately ...

Frozen embryos more successful for conceiving during IVF

March 19, 2018
A new study carried out by a research team at The University of Western Australia and Fertility Specialists of Western Australia has found that women undergoing IVF who have had embryos fail to implant have more success using ...

Alomst 70 percent of 103 genes linked to prenatal death affect the placenta

March 14, 2018
The role of the placenta in healthy fetal development is being seriously under-appreciated according to a new paper published today (14th March). The study was part of the Wellcome Trust-funded "Deciphering the Mechanisms ...

New research shows why babies need to move in the womb

March 12, 2018
Scientists have just discovered why babies need to move in the womb to develop strong bones and joints. It turns out there are some key molecular interactions that are stimulated by movement and which guide the cells and ...

Labour–inducing drugs put to the test

February 27, 2018
Researchers comparing the use of two drugs for pregnant women who do not go into labour shortly after their waters break have found both are reasonable options.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.